Abstract
The NCCN Clinical Practice Guidelines in Oncology for Survivorship include a new section on cancer-associated cognitive impairment and an expanded section on adult cancer pain that more completely addresses chemotherapy-induced peripheral neuropathy. These additions to the guidelines are the result of increasing awareness that long-term cancer survivors struggle with many late effects. Both the assessment and the management of cognitive impairment still lack a strong evidence-based foundation. The management of peripheral neuropathy, including the use of antidepressants and opioids, often in combination, is backed by data primarily derived from clinical trials performed for various types of peripheral neuropathy. © JNCCN - Journal of the National Comprehensive Cancer Network.
Cite
CITATION STYLE
Kvale, E., & Urba, S. G. (2014). NCCN guidelines for survivorship expanded to address two common conditions. In JNCCN Journal of the National Comprehensive Cancer Network (Vol. 12, pp. 825–827). Harborside Press. https://doi.org/10.6004/jnccn.2014.0199
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.